domains / families / business / biotech-pitch-deck-narrative

biotech-pitch-deck-narrative

combined

Use when creating biotech pitch decks, translating scientific data for investors, preparing fundraising presentations, or developing investor Q&A. Transforms complex scientific and clinical data into compelling investor narratives for biotech fundraising. Use biotech-pitch-deck-narrative for academic writing workflows that need structured investor-facing storytelling, explicit assumptions, and clear output boundaries.

When to use

• Preparing Series A/B pitch decks for VC presentations
• Creating management presentations for IPO roadshows
• Developing BD materials for pharma partnership discussions
• Crafting executive summaries for grant applications
• Rehearsing investor Q&A for earnings calls
• Translating clinical data into commercial narratives
• Adapting academic presentations for business audiences
• Scientific conference presentations → Use technical language

When not to use

• **Not Financial Advice**: Cannot provide investment recommendations
• **Regulatory Compliance**: Does not ensure SEC or other regulatory compliance
• **Market Specificity**: May not capture niche investor preferences
• **Real-Time Adaptation**: Cannot adjust to live investor reactions
• **Confidentiality**: Does not handle material non-public information protection
• **Legal Review**: All materials require legal counsel review before use

Skill page

Conflict

The two copies overlap in purpose (biotech fundraising narrative) but each contains material steps the other lacks. The aipoch copy is a bounded, script-driven workflow with explicit stop conditions, a parameter table, and a risk/security checklist. The LeoYeAI copy is a content-generation workflow with a Python narrative engine, specific translation tables, a 7-part narrative architecture, and stage/audience calibration logic. Neither is a reproduction of the other; crowning one would hide a real alternative approach.